Willis Towers Watson PLC WTW
We take great care to ensure that the data presented and summarized in this overview for WILLIS TOWERS WATSON PLC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding WTW
View all-
Vanguard Group Inc Valley Forge, PA11.3MShares$3.69 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.96MShares$3.26 Billion0.06% of portfolio
-
Massachusetts Financial Services CO Boston, MA6.24MShares$2.05 Billion0.65% of portfolio
-
State Street Corp Boston, MA4.36MShares$1.43 Billion0.06% of portfolio
-
First Eagle Investment Management, LLC4.29MShares$1.41 Billion2.67% of portfolio
-
Harris Associates L P Chicago, IL3.56MShares$1.17 Billion2.13% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.52MShares$1.15 Billion2.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.86MShares$936 Million0.64% of portfolio
-
Geode Capital Management, LLC Boston, MA2.59MShares$849 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA2.18MShares$713 Million0.15% of portfolio
Latest Institutional Activity in WTW
Top Purchases
Top Sells
About WTW
Willis Towers Watson Public Limited Company operates as an advisory, broking, and solutions company worldwide. It operates through two segments, Health, Wealth and Career; and Risk and Broking. The company offers actuarial support, plan design, and administrative services for traditional pension and retirement savings plans; plan management consulting, broking, and administration services for health and group benefit programs; and benefits outsourcing services. It also provides advice, data, software, and products to address clients' total rewards and talent issues. In addition, the company offers risk advice, insurance brokerage, and consulting services in the areas of property and casualty, aerospace, construction, and marine. Further, it offers investment consulting and discretionary management services to insurance and reinsurance companies; insurance consulting and technology, risk and capital management, pricing and predictive modeling, financial and regulatory reporting, financial and capital modeling, merger and acquisition, outsourcing, and business management services; wholesale insurance broking services to retail and wholesale brokers; and underwriting and capital management, capital market, and advisory and brokerage services. Additionally, the company provides primary medical and ancillary benefit exchange, and outsourcing services to active employees and retirees in the group and individual markets, as well as delivers healthcare and reimbursement accounts, including health savings accounts, health reimbursement arrangements, flexible spending accounts, and other consumer-directed accounts. The company was formerly known as Willis Group Holdings Public Limited Company and changed its name to Willis Towers Watson Public Limited Company in January 2016. Willis Towers Watson Public Limited Company was founded in 1828 and is based in London, the United Kingdom.
Insider Transactions at WTW
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 15
2025
|
Julie Jarecke Gebauer Pres.-Health, Wealth & Career |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.01%
|
-
|
Jul 15
2025
|
Alexis Faber Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.06%
|
-
|
Jul 15
2025
|
Kristy D Banas Chief Human Resources Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.05%
|
-
|
Jul 15
2025
|
Andrew Jay Krasner Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12
+0.3%
|
-
|
Jul 15
2025
|
Carl Aaron Hess Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.05%
|
-
|
Jul 15
2025
|
Matthew Furman General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.01%
|
-
|
Jul 15
2025
|
Anne Pullum Head of Europe |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.03%
|
-
|
Jul 15
2025
|
Joseph Stephen Kurpis PAO and Controller |
BUY
Grant, award, or other acquisition
|
Direct |
0
|
-
|
Jul 15
2025
|
Pamela Thomson Hall Head of International |
BUY
Grant, award, or other acquisition
|
Direct |
4
+0.07%
|
-
|
Jul 15
2025
|
Lucy Clarke President of Risk & Broking |
BUY
Grant, award, or other acquisition
|
Direct |
44
+0.25%
|
-
|
Jul 15
2025
|
Imran Ahmed Qureshi Head of North America |
BUY
Grant, award, or other acquisition
|
Direct |
5
+0.06%
|
-
|
Jun 03
2025
|
Andrew Jay Krasner Chief Financial Officer |
SELL
Open market or private sale
|
Indirect |
1,600
-11.78%
|
$504,000
$315.75 P/Share
|
May 15
2025
|
Inga K Beale Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+23.86%
|
-
|
May 15
2025
|
Inga K Beale Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-20.96%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Jacqueline Hunt Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+29.59%
|
-
|
May 15
2025
|
Jacqueline Hunt Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-29.64%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Michael P. Hammond Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+23.86%
|
-
|
May 15
2025
|
Michael P. Hammond Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-20.96%
|
$124,836
$303.37 P/Share
|
May 15
2025
|
Stephen M. Chipman Director |
BUY
Grant, award, or other acquisition
|
Direct |
709
+29.59%
|
-
|
May 15
2025
|
Stephen M. Chipman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
412
-29.64%
|
$124,836
$303.37 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 115K shares |
---|---|
Exercise of in-the-money or at-the-money derivatives securities | 197 shares |
Exercise of conversion of derivative security | 387 shares |
Payment of exercise price or tax liability | 53.9K shares |
---|---|
Open market or private sale | 16.9K shares |